Clinical events and healthcare resource utilization associated with neutropenia and leukopenia among adult kidney transplant recipients receiving valganciclovir

Table 4 Adjusted proportion with no events except mortality, by year after kidney transplantation

Proportion of patients with no event (except for mortality)	Year 1 of follow-up, n = 15398			Year 2-5 of follow-up, n = 14618
	With leukopenia/neutropenia, n = 11524 (A), %	Without leukopenia/neutropenia, n = 3874 (B), %	Relative risk A/B	With leukopenia/neutropenia, n = 5583 (A), %	Without leukopenia/neutropenia, n = 9035 (B), %	Relative risk A/B
No event	17.78	27.54	0.65	18.88	32.77	0.58